ODDB.org: Open Drug Database

Pfizer AG - Campto 100 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	53470	Sequence	02
Product name	Campto 100 mg/5 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01CE02	ATC-Description	Irinotecan
Introduction of Sequence	08.05.1998

Composition

irinotecani hydrochloridum trihydricum 100 mg, sorbitolum 225 mg, acidum lacticum, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100 mg

BAG: Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	100 mg

Inactive agents	Dose
Lactic Acid
Sodium Hydroxide
Sorbitol	225 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
047	Durchstechflasche(n)	107.78	132.65	A	SL	Yes

2025	©ywesee GmbH